CRISPRs Enlisted to Study Mutations Across an Entire Mammalian Genome
By GEN,
Genetic Engineering & Biotechnology News
| 12. 24. 2013
Scientists at the Wellcome Trust Sanger Institute have developed a technique to create a comprehensive library of mutations across all genes in the mouse genome. This library can be used to examine the role of every gene in different cell types, the researchers say.
CRISPR technology uses the DNA-cutting enzyme Cas9, with the help of a guide RNA sequence, to find and modify genetic targets. Scientists engineer multiple new guide RNAs using standard molecular biology techniques. This makes for a much faster and efficient method to modify the genome of any cell type in any species, according to the Wellcome group.
The team, which published their results online (“Genome-wide recessive genetic screening in mammalian cells with a lentiviral CRISPR-guide RNA library”) in Nature Biotechnology, found that 50 of 52 guide RNAs tested successfully cut both copies of the genes. The high success rate for these engineered guide RNAs seems to be consistent across many cell types, which led them to create a library of guide RNAs targeting every gene in the mouse genome.
“We designed 87,897 guide RNAs (gRNAs) targeting...
Related Articles
By Jason Liebowitz, The New Yorker | 03.06.2026
When Talaya Reid was in high school, in a quiet suburb of Philadelphia, she developed fatigue so severe that she spent afternoons napping instead of going out with friends. She was lethargic at school and her grades suffered, but after...
By Tania Fabo, Truthout | 02.28.2026
The reproductive tech company Orchid recently launched a genetic test that promises a whole genome sequencing report for embryos. It is the first such test commercially available to couples undergoing in vitro fertilization (IVF) and claims to detect things like...
By Pete Shanks
| 02.27.2026
Last month, we published “The Shameful Legacy of Tuskegee” which focused on a proposed experiment in Guinea-Bissau. The study’s plan echoed the notorious Tuskegee disaster, withholding safe, effective vaccines against hepatitis B from some newborns while inoculating others. It was to be financed by the U.S. but performed by a controversial Danish team. That project provoked a multi-national outcry, leading to a remarkable response from the World Health Organization:
WHO has significant concerns regarding the study’s scientific...
By Jenn White, NPR | 02.26.2026